Description
| Strength | 100 mg |
| Brand | Mabtas |
| Manufacturer | Intas |
| Packaging Type | Box |
| Packaging Size | 10 ml |
| Usage/Application | Certain Types Of Blood Cancers |
| Shelf Life | 24 Months |
| Composition | Rituximab |
| Form | Liquid |
Product’s Details:
- Rituximab is a synthetic antibody (protein) that can target antigens or substances that can cause an immune response. This medication treats non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis and pemphigus vulgaris.
- Mechanism of Action:
- Rituximab binds to CD20 on B-cells, causing their destruction, which helps in controlling abnormal immune responses and treating cancerous growths
- Precautions:
- Must be administered in a healthcare setting with emergency support.
- Risk of infusion reactions (fever, chills, rash, breathing issues).
- Monitor for infections, blood counts and liver function.
- Use with caution in patients with heart problems or weakened immunity.
- Storage:
- Store at 2°C to 8°C (Refrigerated).
- Do not freeze or shake.
- Protect from light.








Reviews
There are no reviews yet.